Evaluation of Recurrent Gross Hematuria in a Patient With Metastatic Prostate and Concomitant Metastatic Kidney Cancer

被引:0
|
作者
Maas, Marissa [1 ]
Chen, Andrew [1 ]
Asanad, Kian [1 ]
Nabhani, Jamal [1 ,2 ,3 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Inst Urol, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Inst Urol, Keck Sch Med, Clin Adm LAC USC, Los Angeles, CA 90007 USA
[3] Univ Southern Calif, Inst Urol, Keck Sch Med, Clin Urol, Los Angeles, CA 90007 USA
关键词
D O I
10.1016/j.urology.2023.03.031
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This is a 67-year-old man with a history of atrial fibrillation (CHADS-VASc Score of 3 on therapeutic (baseline creatine 2.2), and metastatic prostate cancer treated with androgen deprivation therapy and docetaxel as well as channel transurethral resection of the prostate for bothersome lower urinary tract symptoms. He presented with a pathologic femur fracture and biopsy demonstrated clear cell renal cell carcinoma. Computed tomography urogram demonstrated an 8-cm left inferior pole renal mass (Fig. 1). Patient subsequently developed recurrent clot hematuria despite holding his anticoagulation and intermittent improvement with bladder catheter drainage and continuous bladder irrigation.
引用
收藏
页码:E1 / E2
页数:2
相关论文
共 50 条
  • [1] Molecular Imaging of Recurrent and Metastatic Prostate Cancer
    Ware, Robert E.
    Williams, Scott
    Hicks, Rodney J.
    SEMINARS IN NUCLEAR MEDICINE, 2019, 49 (04) : 280 - 293
  • [2] ASSOCIATION OF RECURRENT THROMBOEMBOLISM FROM MARANTIC ENDOCARDITIS IN A PATIENT WITH METASTATIC PROSTATE CANCER
    Kim, Doyoung
    Jarrar, Ahmad
    Nicholson, Charles
    Khan, Muhammad Z.
    McLaughlin, Carlin
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S403 - S404
  • [3] Evaluation of metastatic potential of prostate cancer
    Chihara, Yoshitomo
    Fujimoto, Kiyohide
    Hirao, Yoshihiko
    Kuniyasu, Hiroki
    ONCOLOGY REVIEWS, 2011, 5 (02) : 103 - 107
  • [4] Recurrent Strokes in a Patient With Metastatic Lung Cancer
    Karkra, Rohan
    Jain, Riya
    Shivaswamy, Rajendra P.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [5] Patient treatment preference in metastatic prostate cancer
    Creagh, T
    IRISH MEDICAL JOURNAL, 1996, 89 (01) : 12 - 12
  • [6] FDG PET in suspected recurrent and metastatic prostate cancer
    Jadvar, H
    Pinski, JK
    Conti, PS
    ONCOLOGY REPORTS, 2003, 10 (05) : 1485 - 1488
  • [7] Acquired color blindness in an elderly male patient from recurrent metastatic prostate cancer
    Harper, DG
    Arsura, EL
    Bobba, RK
    Reddy, CM
    Sawh, AK
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (07) : 1265 - 1267
  • [8] Hematuria in a patient with prostate cancer
    Vakulenko, M.
    Vanderwalde, A.
    Navarro, G. M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 143 - 144
  • [9] The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer
    Kase, Adam M.
    Tan, Winston
    Copland, John A., III
    Cai, Hancheng
    Parent, Ephraim E.
    Madan, Ravi A.
    CANCERS, 2022, 14 (06)
  • [10] Unusual metastatic features in a patient with concomitant malignant orbital melanoma and prostate carcinoma
    Ars, C
    Duck, L
    Baurain, JF
    Moulin, P
    Duprez, T
    Machiels, JP
    JOURNAL OF NEURO-ONCOLOGY, 2004, 66 (03) : 361 - 363